Freestone Grove Partners LP Invests $102.52 Million in IDEX Corporation $IEX

Freestone Grove Partners LP purchased a new stake in shares of IDEX Corporation (NYSE:IEX) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 451,742 shares of the industrial products company’s stock, valued at approximately $102,523,000. IDEX accounts for about 0.7% of Freestone Grove Partners LP’s holdings, making the stock its 24th largest position.

Several other institutional investors and hedge funds have also recently made changes to their positions in IEX. Laurel Wealth Advisors LLC bought a new position in IDEX during the 4th quarter worth about $27,000. Optiver Holding B.V. bought a new stake in shares of IDEX in the 1st quarter valued at about $27,000. SJS Investment Consulting Inc. raised its holdings in shares of IDEX by 104.1% in the 1st quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock valued at $28,000 after purchasing an additional 76 shares in the last quarter. Quantbot Technologies LP purchased a new stake in shares of IDEX in the 2nd quarter worth approximately $33,000. Finally, CYBER HORNET ETFs LLC purchased a new stake in shares of IDEX in the 2nd quarter worth approximately $35,000. 97.96% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CAO Lisa M. Anderson sold 385 shares of the company’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total transaction of $91,857.15. Following the transaction, the chief accounting officer directly owned 4,327 shares of the company’s stock, valued at approximately $1,032,378.93. This represents a 8.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.50% of the company’s stock.

Key IDEX News

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
• Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
• Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
• Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
• Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
• Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement

IDEX Stock Up 2.0%

NYSE:IEX opened at $234.91 on Thursday. IDEX Corporation has a fifty-two week low of $158.19 and a fifty-two week high of $243.80. The stock has a market capitalization of $17.32 billion, a P/E ratio of 33.80, a P/E/G ratio of 2.17 and a beta of 0.98. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.15 and a current ratio of 3.05. The company’s 50-day simple moving average is $228.47 and its 200-day simple moving average is $213.48.

IDEX (NYSE:IEX) last posted its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, topping the consensus estimate of $2.11 by $0.21. The firm had revenue of $920.60 million during the quarter, compared to analyst estimates of $905.38 million. IDEX had a net margin of 14.49% and a return on equity of 15.69%. IDEX’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.07 EPS. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, equities analysts anticipate that IDEX Corporation will post 8.82 earnings per share for the current fiscal year.

IDEX Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Monday, July 6th were issued a $0.73 dividend. This represents a $2.92 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend was Monday, July 6th. IDEX’s payout ratio is currently 42.01%.

Analyst Ratings Changes

IEX has been the topic of several research reports. Robert W. Baird set a $257.00 price objective on shares of IDEX in a report on Thursday, April 30th. Argus upped their target price on IDEX from $250.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Citigroup increased their target price on IDEX from $252.00 to $269.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. TD Cowen lifted their price target on IDEX from $260.00 to $275.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Finally, Stifel Nicolaus boosted their price target on IDEX from $257.00 to $268.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Eight analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $260.80.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.